{
  "DOI": "10.1007/s10689-021-00254-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-021-00254-0",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eIncreasing use of genomic sequencing enables standardized screening of all childhood cancer predisposition syndromes (CPS) in children with cancer. Gene panels currently used often include adult-onset CPS genes and genes without substantial evidence linking them to cancer predisposition. We have developed criteria to select genes relevant for childhood-onset CPS and assembled a gene panel for use in children with cancer. We applied our criteria to 381 candidate genes, which were selected through two in-house panels (n = 338), a literature search (n = 39), and by assessing two Genomics England’s PanelApp panels (n = 4). We developed evaluation criteria that determined a gene’s eligibility for inclusion on a childhood-onset CPS gene panel. These criteria assessed (1) relevance in childhood cancer by a minimum of five childhood cancer patients reported carrying a pathogenic variant in the gene and (2) evidence supporting a causal relation between variants in this gene and cancer development. 138 genes fulfilled the criteria. In this study we have developed criteria to compile a childhood cancer predisposition gene panel which might ultimately be used in a clinical setting, regardless of the specific type of childhood cancer. This panel will be evaluated in a prospective study. The panel is available on (pediatric-cancer-predisposition-genepanel.nl) and will be regularly updated.\u003c/jats:p\u003e",
  "alternative-id": [
    "254"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "14 September 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "7 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "1 June 2021"
    },
    {
      "group": {
        "label": "Declaration",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflicts of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no conflicts of interest – financial or otherwise."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-3470-5995",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Byrjalsen",
      "given": "Anna",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-7603-8898",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Diets",
      "given": "Illja J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bakhuizen",
      "given": "Jette",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hansen",
      "given": "Thomas van Overeem",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Schmiegelow",
      "given": "Kjeld",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gerdes",
      "given": "Anne-Marie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stoltze",
      "given": "Ulrik",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kuiper",
      "given": "Roland P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Merks",
      "given": "Johannes H. M.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2882-6798",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Wadt",
      "given": "Karin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jongmans",
      "given": "Marjolijn",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        6,
        1
      ]
    ],
    "date-time": "2021-06-01T06:03:36Z",
    "timestamp": 1622527416000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        9,
        30
      ]
    ],
    "date-time": "2021-09-30T07:45:42Z",
    "timestamp": 1632987942000
  },
  "funder": [
    {
      "award": [
        "COST Action AC16223"
      ],
      "name": "LEukemia GENe Discovery by data sharing, mining and collaboration"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T16:16:37Z",
    "timestamp": 1712333797462
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2021,
        6,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2021,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            6,
            1
          ]
        ],
        "date-time": "2021-06-01T00:00:00Z",
        "timestamp": 1622505600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            6,
            1
          ]
        ],
        "date-time": "2021-06-01T00:00:00Z",
        "timestamp": 1622505600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00254-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-021-00254-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-021-00254-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "279-287",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        6,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        6,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/ijc.25516",
      "author": "J Ferlay",
      "doi-asserted-by": "publisher",
      "first-page": "2893",
      "journal-title": "Int J Cancer",
      "key": "254_CR1",
      "unstructured": "Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. https://doi.org/10.1002/ijc.25516",
      "volume": "127",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMoa1508054",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2336",
      "journal-title": "N Engl J Med",
      "key": "254_CR2",
      "unstructured": "Zhang J, Walsh MF, Wu G et al (2015) Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 373:2336–2346. https://doi.org/10.1056/NEJMoa1508054",
      "volume": "373",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.5699",
      "author": "DW Parsons",
      "doi-asserted-by": "publisher",
      "first-page": "616",
      "journal-title": "JAMA Oncol",
      "key": "254_CR3",
      "unstructured": "Parsons DW, Roy A, Yang Y et al (2016) Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol 2:616–624. https://doi.org/10.1001/jamaoncol.2015.5699",
      "volume": "2",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jama.2015.10080",
      "author": "RJ Mody",
      "doi-asserted-by": "publisher",
      "first-page": "913",
      "journal-title": "JAMA J Am Med Assoc",
      "key": "254_CR4",
      "unstructured": "Mody RJ, Wu YM, Lonigro RJ et al (2015) Integrative clinical sequencing in the management of refractory or relapsed cancer in youth. JAMA J Am Med Assoc 314:913–925. https://doi.org/10.1001/jama.2015.10080",
      "volume": "314",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmedgenet-2017-104976",
      "author": "M Renaux-Petel",
      "doi-asserted-by": "publisher",
      "first-page": "173",
      "journal-title": "J Med Genet",
      "key": "254_CR5",
      "unstructured": "Renaux-Petel M, Charbonnier F, Théry JC et al (2018) Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome. J Med Genet 55:173–180. https://doi.org/10.1136/jmedgenet-2017-104976",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-0381",
      "author": "AC Harttrampf",
      "doi-asserted-by": "publisher",
      "first-page": "6101",
      "journal-title": "Clin Cancer Res",
      "key": "254_CR6",
      "unstructured": "Harttrampf AC, Lacroix L, Deloger M et al (2017) Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial. Clin Cancer Res 23:6101–6112. https://doi.org/10.1158/1078-0432.CCR-17-0381",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ejca.2016.06.009",
      "author": "BC Worst",
      "doi-asserted-by": "publisher",
      "first-page": "91",
      "journal-title": "Eur J Cancer",
      "key": "254_CR7",
      "unstructured": "Worst BC, van Tilburg CM, Balasubramanian GP et al (2016) Next-generation personalised medicine for high-risk paediatric cancer patients—the INFORM pilot study. Eur J Cancer 65:91–101. https://doi.org/10.1016/j.ejca.2016.06.009",
      "volume": "65",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2000.18.10.2135",
      "author": "M Dorval",
      "doi-asserted-by": "publisher",
      "first-page": "2135",
      "journal-title": "J Clin Oncol",
      "key": "254_CR8",
      "unstructured": "Dorval M, Patenaude AF, Schneider KA et al (2000) Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 18:2135–2142. https://doi.org/10.1200/JCO.2000.18.10.2135",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s10897-017-0091-x",
      "author": "MA Alderfer",
      "doi-asserted-by": "publisher",
      "first-page": "1106",
      "journal-title": "J Genet Couns",
      "key": "254_CR9",
      "unstructured": "Alderfer MA, Lindell RB, Viadro CI et al (2017) Should genetic testing be offered for children? The perspectives of adolescents and emerging adults in families with Li-Fraumeni syndrome. J Genet Couns 26:1106–1115. https://doi.org/10.1007/s10897-017-0091-x",
      "volume": "26",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2009.27.2112",
      "author": "CRM Lammens",
      "doi-asserted-by": "publisher",
      "first-page": "3008",
      "journal-title": "J Clin Oncol",
      "key": "254_CR10",
      "unstructured": "Lammens CRM, Aaronson NK, Wagner A et al (2010) Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences. J Clin Oncol 28:3008–3014. https://doi.org/10.1200/JCO.2009.27.2112",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41431-018-0284-2",
      "author": "L Haer-Wigman",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "Eur J Hum Genet",
      "key": "254_CR11",
      "unstructured": "Haer-Wigman L, van der Schoot V, Feenstra I et al (2019) 1 in 38 individuals at risk of a dominant medically actionable disease. Eur J Hum Genet 27:325–330. https://doi.org/10.1038/s41431-018-0284-2",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ejmg.2018.08.010",
      "author": "J Delanne",
      "doi-asserted-by": "publisher",
      "first-page": "103529",
      "journal-title": "Eur. J. Med. Genet.",
      "key": "254_CR12",
      "unstructured": "Delanne J, Nambot S, Chassagne A et al (2019) Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature. Eur. J. Med. Genet. 62:103529",
      "volume": "62",
      "year": "2019"
    },
    {
      "DOI": "10.1038/gim.2016.190",
      "author": "SS Kalia",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "journal-title": "Genet Med",
      "key": "254_CR13",
      "unstructured": "Kalia SS, Adelman K, Bale SJ et al (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19:249–255. https://doi.org/10.1038/gim.2016.190",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1111/cge.13649",
      "author": "E Castellanos",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "journal-title": "Clin Genet",
      "key": "254_CR14",
      "unstructured": "Castellanos E, Rosas I, Negro A et al (2020) Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules. Clin Genet 97:264–275. https://doi.org/10.1111/cge.13649",
      "volume": "97",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.jmoldx.2018.06.009",
      "author": "MC Hiemenz",
      "doi-asserted-by": "publisher",
      "first-page": "765",
      "journal-title": "J Mol Diagnostics",
      "key": "254_CR15",
      "unstructured": "Hiemenz MC, Ostrow DG, Busse TM et al (2018) OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies. J Mol Diagnostics 20:765–776. https://doi.org/10.1016/j.jmoldx.2018.06.009",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/ejhg.2009.26",
      "author": "European Society of Human Genetics",
      "doi-asserted-by": "publisher",
      "first-page": "720",
      "journal-title": "Eur J Hum Genet",
      "key": "254_CR16",
      "unstructured": "European Society of Human Genetics (2009) Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet 17:720–721. https://doi.org/10.1038/ejhg.2009.26",
      "volume": "17",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nature12981",
      "author": "N Rahman",
      "doi-asserted-by": "publisher",
      "first-page": "302",
      "journal-title": "Nature",
      "key": "254_CR17",
      "unstructured": "Rahman N (2014) Realizing the promise of cancer predisposition genes. Nature 505:302–308",
      "volume": "505",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature25480",
      "author": "SN Gröbner",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Nature",
      "key": "254_CR18",
      "unstructured": "Gröbner SN, Worst BC, Weischenfeldt J et al (2018) The landscape of genomic alterations across childhood cancers. Nature 555:321–327. https://doi.org/10.1038/nature25480",
      "volume": "555",
      "year": "2018"
    },
    {
      "DOI": "10.1136/medethics-2016-103943",
      "author": "AJ Newson",
      "doi-asserted-by": "publisher",
      "journal-title": "J Med Ethics",
      "key": "254_CR19",
      "unstructured": "Newson AJ (2017) Whole genome sequencing in children: ethics, choice and deliberation. J Med Ethics. https://doi.org/10.1136/medethics-2016-103943",
      "year": "2017"
    },
    {
      "DOI": "10.1136/medethics-2016-103564",
      "author": "JA Anderson",
      "doi-asserted-by": "publisher",
      "journal-title": "J Med Ethics",
      "key": "254_CR20",
      "unstructured": "Anderson JA, Meyn MS, Shuman C et al (2016) Parents perspectives on whole genome sequencing for their children: qualified enthusiasm? J Med Ethics. https://doi.org/10.1136/medethics-2016-103564",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "254_CR21",
      "unstructured": "Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ajhg.2017.04.015",
      "author": "NT Strande",
      "doi-asserted-by": "publisher",
      "first-page": "895",
      "journal-title": "Am J Hum Genet",
      "key": "254_CR22",
      "unstructured": "Strande NT, Riggs ER, Buchanan AH et al (2017) Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am J Hum Genet 100:895–906. https://doi.org/10.1016/j.ajhg.2017.04.015",
      "volume": "100",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-1725",
      "author": "IJ Diets",
      "doi-asserted-by": "publisher",
      "first-page": "1594",
      "journal-title": "Clin Cancer Res",
      "key": "254_CR23",
      "unstructured": "Diets IJ, Waanders E, Ligtenberg MJ et al (2018) High yield of pathogenic germline mutations causative or likely causative of the cancer phenotype in selected children with cancer. Clin Cancer Res 24:1594–1603. https://doi.org/10.1158/1078-0432.CCR-17-1725",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1470-2045(18)30242-0",
      "author": "SM Waszak",
      "doi-asserted-by": "publisher",
      "first-page": "785",
      "journal-title": "Lancet Oncol",
      "key": "254_CR24",
      "unstructured": "Waszak SM, Northcott PA, Buchhalter I et al (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785–798. https://doi.org/10.1016/S1470-2045(18)30242-0",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2014.59.5728",
      "author": "G Bougeard",
      "doi-asserted-by": "publisher",
      "first-page": "2345",
      "journal-title": "J Clin Oncol",
      "key": "254_CR25",
      "unstructured": "Bougeard G, Renaux-Petel M, Flaman JM et al (2015) Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol 33:2345–2352. https://doi.org/10.1200/JCO.2014.59.5728",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1002/pbc.27390",
      "author": "C Goudie",
      "doi-asserted-by": "publisher",
      "first-page": "e27390",
      "journal-title": "Pediatr Blood Cancer",
      "key": "254_CR26",
      "unstructured": "Goudie C, Cullinan N, Villani A et al (2018) Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors. Pediatr Blood Cancer 65:e27390. https://doi.org/10.1002/pbc.27390",
      "volume": "65",
      "year": "2018"
    },
    {
      "DOI": "10.1111/ecc.12877",
      "author": "A Byrjalsen",
      "doi-asserted-by": "publisher",
      "journal-title": "Eur J Cancer Care (Engl)",
      "key": "254_CR27",
      "unstructured": "Byrjalsen A, Stoltze U, Wadt K et al (2018) Pediatric cancer families’ participation in whole-genome sequencing research in Denmark: parent perspectives. Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.12877",
      "year": "2018"
    }
  ],
  "reference-count": 27,
  "references-count": 27,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-021-00254-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "20"
}